Issue 8/2022
Content (12 Articles)
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
Arndt-Christian Müller, Daniel M. Aebersold, Clemens Albrecht, Dirk Böhmer, Michael Flentje, Ute Ganswindt, Pirus Ghadjar, Nina-Sophie Schmidt-Hegemann, Stefan Höcht, Tobias Hölscher, Peter Niehoff, Michael Pinkawa, Felix Sedlmayer, Frank Wolf, Constantinos Zamboglou, Daniel Zips, Thomas Wiegel
On the probability of lymph node negativity in pN0-staged prostate cancer—a theoretically derived rule of thumb for adjuvant needs
Frank Paulsen, Jens Bedke, Daniel Wegener, Jolanta Marzec, Peter Martus, Dominik Nann, Arnulf Stenzl, Daniel Zips, Arndt-Christian Müller
Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer
Salvatore Cozzi, Andrea Botti, Giorgia Timon, Gladys Blandino, Masoumeh Najafi, Moana Manicone, Lilia Bardoscia, Maria Paola Ruggieri, Patrizia Ciammella, Cinzia Iotti
Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy
Ciro Franzese, Luca Cozzi, Marco Badalamenti, Davide Baldaccini, Giuseppe D’Agostino, Antonella Fogliata, Pierina Navarria, Davide Franceschini, Tiziana Comito, Elena Clerici, Giacomo Reggiori, Stefano Tomatis, Marta Scorsetti
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Matthias Moll, David D’Andrea, Alexandru Zaharie, Bernhard Grubmüller, Christopher Paschen, Sonja Zehetmayer, Shahrokh F. Shariat, Joachim Widder, Gregor Goldner
Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, Dinah Konnerth, Sebastian Marschner, Nina-Sophie Schmidt Hegemann, Claus Belka, Minglun Li
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
Jörg Tamihardja, Ingulf Lawrenz, Paul Lutyj, Stefan Weick, Matthias Guckenberger, Bülent Polat, Michael Flentje
Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam
Chao Ge, Huidong Wang, Kunzhi Chen, Wuji Sun, Huicheng Li, Yinghua Shi
Die Wahl der Chemotherapie unter einer PET-CT-geführten Therapiedeeskalation hat einen signifikanten Einfluss auf die Fertilität und Lebensqualität junger Hodgkin-Patientinnen und Patienten
Ricarda Stella Guninski, Panagiotis Balermpas
Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar II
Robert Michael Hermann, Hans Christiansen
Geschichte der Hypofraktionierung und „die Tabelle an der Wand“
Thomas Brunner
Schwangerschaft nach Brustkrebserkrankung: Ergebnisse eines systematischen Reviews mit Metaanalyse
Rainer Souchon